Registration Now Open for BOS Events 2024!

Bio2Business Ltd is delighted to open registration for BOS Events 2024 which includes: BOS Basel 2024, which will take place on the 19th and 20th of June at Congress Centre Basel; and BOS Manchester 2024, which will take place on the 26th and 27th of November at Manchester Central.

The focus of these events is partnerships in R&D outsourcing with the primary scope being development-stage CMC outsourcing of Small Molecules, Biologics and New Therapeutic Entities.

We continue to evaluate the opportunity for virtual events during 2024. We look forward to welcoming you and your colleagues to BOS Events 2024! Please contact the Bio2Business team for further details.

Follow us on LinkedIn to see our latest announcements


Featured Company (BOS Manchester 2023)

Logo for Summit Pharmaceuticals Europe
Summit Pharmaceuticals Europe
Summit Pharmaceuticals Europe (SPE) is a 100% subsidiary of Summit Pharmaceuticals International Corporation, part of Sumitomo group, one of the leading trading & investment firms in Japan. Ideally located in Milan and Madrid, Summit Pharmaceuticals Europe is a trusted trading partner with a lean organization...
View profile

Featured Speaker (BOS Manchester 2023)

photo of Dr Dr Farid Khan

The Spinout Journey from Drug Repurposing to Clinical Trials for Diagnosing and Treating Alzheimer's Disease

Dr Farid Khan, CEO, Pharmakure Ltd

ABSTRACT: Alzheimer’s disease is a fatal illness that causes progressive decline of brain function and represents 60-80% of dementia cases, affecting 45 million people worldwide. In his presentation at BOS Manchester 2023, Dr. Farid Khan will talk about PharmaKure's exciting journey to identify a new blood based diagnostic for early stage Alzheimer's using a combination of biomarkers and AI. Importantly, this will allow identification of patients for treatment using repurposed drugs targeting B-amyloid. Click here to Read More